BCL2A1 and lymphoma: However, pharmacological inhibition of MCL-1 with AZD5991, in combination with dose-dependent BFL-1 knockdown, induced cell killing, demonstrating that BFL-1 and MCL-1 were crucial for the survival of the lymphoma cells.